Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Sandrim

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Bioprocess and Biosystems Engineering|October 18, 2007
Evidence of thermostable amylolytic activity from Rhizopus microsporus var. rhizopodiformis using wheat bran and corncob as alternative carbon sourceS C Peixoto-Nogueira, V C Sandrim, L H S Guimarães, et al.
Journal of Human Hypertension|July 1, 2011
Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancyL M Amaral, A C T Palei, V C Sandrim, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 6, 2012
Endothelial FOS expression and pre-eclampsiaR M Mackenzie, V C Sandrim, D M Carty, et al.
Journal of Diabetes Research|June 12, 2015
Association of a Large Panel of Cytokine Gene Polymorphisms with Complications and Comorbidities in Type 2 Diabetes PatientsK F Rodrigues, N T Pietrani, V C Sandrim, et al.
Journal of Human Hypertension|December 11, 2012
Haptoglobin polymorphism affects nitric oxide bioavailability in preeclampsiaJ T Sertório, R Lacchini, L M Amaral, et al.
The Pharmacogenomics Journal|July 20, 2011
Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancyA C T Palei, V C Sandrim, L M Amaral, et al.
The Pharmacogenomics Journal|May 12, 2016
Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancyM R Luizon, A C T Palei, V A Belo, et al.
The Pharmacogenomics Journal|June 11, 2014
Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancyM R Luizon, A C T Palei, V C Sandrim, et al.
Pregnancy Hypertension|June 25, 2015
PP070. Maternal flow-mediated dilation and nitrite concentration during third trimester of pregnancy and postpartum periodR C Cavalli, A H Myague, V C Sandrim, et al.
Pregnancy Hypertension|June 25, 2015
PP071. Evaluation of maternal-fetal doppler parameters and of whole blood nitrite throughout gestationR C Cavalli, S D Jorge Neto, V C Sandrim, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Bioprocess and Biosystems Engineering|October 18, 2007
Evidence of thermostable amylolytic activity from Rhizopus microsporus var. rhizopodiformis using wheat bran and corncob as alternative carbon sourceS C Peixoto-Nogueira, V C Sandrim, L H S Guimarães, et al.
Journal of Human Hypertension|July 1, 2011
Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancyL M Amaral, A C T Palei, V C Sandrim, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 6, 2012
Endothelial FOS expression and pre-eclampsiaR M Mackenzie, V C Sandrim, D M Carty, et al.
Journal of Diabetes Research|June 12, 2015
Association of a Large Panel of Cytokine Gene Polymorphisms with Complications and Comorbidities in Type 2 Diabetes PatientsK F Rodrigues, N T Pietrani, V C Sandrim, et al.
Journal of Human Hypertension|December 11, 2012
Haptoglobin polymorphism affects nitric oxide bioavailability in preeclampsiaJ T Sertório, R Lacchini, L M Amaral, et al.
The Pharmacogenomics Journal|July 20, 2011
Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancyA C T Palei, V C Sandrim, L M Amaral, et al.
The Pharmacogenomics Journal|May 12, 2016
Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancyM R Luizon, A C T Palei, V A Belo, et al.
The Pharmacogenomics Journal|June 11, 2014
Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancyM R Luizon, A C T Palei, V C Sandrim, et al.
Pregnancy Hypertension|June 25, 2015
PP070. Maternal flow-mediated dilation and nitrite concentration during third trimester of pregnancy and postpartum periodR C Cavalli, A H Myague, V C Sandrim, et al.
Pregnancy Hypertension|June 25, 2015
PP071. Evaluation of maternal-fetal doppler parameters and of whole blood nitrite throughout gestationR C Cavalli, S D Jorge Neto, V C Sandrim, et al.
Pageof 3